Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

200 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Health-related quality of life and its influencing factors in patients with primary cutaneous B-cell lymphomas: A multicentric study in 100 patients.
Schirren AEC, Albrecht JD, Melchers S, Weiß C, Büttner S, Dippel E, Gosmann J, Jonak C, Klemke CD, Laturnus-Chang M, Livingstone E, Mitteldorf C, Schummer P, Stadler R, Stranzenbach R, Weyer-Fahlbusch SS, Wobser M, Ziemer M, Nicolay JP. Schirren AEC, et al. Among authors: livingstone e. J Eur Acad Dermatol Venereol. 2024 May;38(5):954-966. doi: 10.1111/jdv.19799. Epub 2024 Jan 26. J Eur Acad Dermatol Venereol. 2024. PMID: 38279594
Actual practice of melanoma follow-up and treatment in Germany: results of a prospective, longitudinal cohort study.
Livingstone E, Eigentler TK, Windemuth-Kieselbach C, Hauschild A, Rompel R, Trefzer U, Nashan D, Kilian K, Debus D, Kähler KC, Mauerer A, Möllenhoff K, Dippel E, Schadendorf D. Livingstone E, et al. Br J Dermatol. 2015 Jun;172(6):1646-1650. doi: 10.1111/bjd.13612. Epub 2015 Apr 29. Br J Dermatol. 2015. PMID: 25495472 No abstract available.
Prospective evaluation of follow-up in melanoma patients in Germany - results of a multicentre and longitudinal study.
Livingstone E, Krajewski C, Eigentler TK, Windemuth-Kieselbach C, Benson S, Elsenbruch S, Hauschild A, Rompel R, Meiss F, Mauerer A, Kähler KC, Dippel E, Möllenhoff K, Kilian K, Mohr P, Utikal J, Schadendorf D. Livingstone E, et al. Eur J Cancer. 2015 Mar;51(5):653-67. doi: 10.1016/j.ejca.2015.01.007. Epub 2015 Jan 28. Eur J Cancer. 2015. PMID: 25638778
Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a randomised, double-blind, placebo-controlled, phase 2 trial.
Zimmer L, Livingstone E, Hassel JC, Fluck M, Eigentler T, Loquai C, Haferkamp S, Gutzmer R, Meier F, Mohr P, Hauschild A, Schilling B, Menzer C, Kieker F, Dippel E, Rösch A, Simon JC, Conrad B, Körner S, Windemuth-Kieselbach C, Schwarz L, Garbe C, Becker JC, Schadendorf D; Dermatologic Cooperative Oncology Group. Zimmer L, et al. Among authors: livingstone e. Lancet. 2020 May 16;395(10236):1558-1568. doi: 10.1016/S0140-6736(20)30417-7. Lancet. 2020. PMID: 32416781 Clinical Trial.
Quality of life in patients with mycosis fungoides and Sézary syndrome undergoing low-dose total skin electron beam therapy with or without maintenance therapy.
Nawar T, Elsayad K, Müller EC, Rolf D, Moritz RKC, Bormann E, Weishaupt C, Stranzenbach R, Stadler R, Moustakis C, Assaf C, Livingstone E, Sunderkötter C, Steinbrink K, Eich HT. Nawar T, et al. Among authors: livingstone e. J Am Acad Dermatol. 2022 Apr;86(4):889-891. doi: 10.1016/j.jaad.2021.03.025. Epub 2021 Mar 17. J Am Acad Dermatol. 2022. PMID: 33722549 No abstract available.
Management of partial and non-responding cutaneous squamous cell carcinoma.
Jansen P, Lodde GC, Griewank KG, Hadaschik E, Roesch A, Ugurel S, Zimmer L, Livingstone E, Schadendorf D. Jansen P, et al. Among authors: livingstone e. J Eur Acad Dermatol Venereol. 2022 Jan;36 Suppl 1:29-34. doi: 10.1111/jdv.17404. J Eur Acad Dermatol Venereol. 2022. PMID: 34855242 Review.
Checkpoint immunotherapy of cutaneous squamous cell carcinoma in patients suffering from chronic lymphocytic leukaemia: divergent outcomes in two men treated with PD-1 inhibitors.
Jansen P, Lodde GC, Wetter A, Welt A, Stuschke M, Dührsen U, Stoffels I, Klode J, Livingstone E, Zimmer L, Roesch A, Hadaschik E, Griewank KG, Schadendorf D, Ugurel S. Jansen P, et al. Among authors: livingstone e. J Eur Acad Dermatol Venereol. 2022 Jan;36 Suppl 1:41-44. doi: 10.1111/jdv.17405. J Eur Acad Dermatol Venereol. 2022. PMID: 34855243
200 results